NICE urgent cancer referral guidance (guidelines with respect to primary care investigations)
This part of the database outlines NICE urgent cancer referral guidance with respect to possible investigations (and results from these) undertaken in primary care.
Reference:
Related pages
- Urgent referral guidelines (patients with suspected cancer)
- NICE urgent cancer referral guidance (guidelines with respect to presenting symptoms and signs)
- Anaemia - NICE urgent cancer referral guidance
- Blood glucose levels - NICE urgent cancer referral guidance
- Hypercalcaemia or leukopenia and presentation consistent with possible myeloma, 60 and over - NICE urgent cancer referral guidance
- Plasma viscosity (PV) or erythrocyte sedimentation rate (ESR) and presentation consistent with possible myeloma - NICE urgent cancer referral guidance
- Urological cancer (urgent referral guidance for suspected cancer)
- Protein electrophoresis suggests myeloma - NICE urgent cancer referral guidance
- Ca125 (Ca - 125) - NICE urgent cancer referral guidance
- Raised platelet count (thrombocytosis) - NICE urgent cancer referral guidance
- Raised white cell count - NICE urgent cancer referral guidance
- NICE guidance - use of faecal occult blood (FOB) testing to identify possible colorectal cancer
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.